Name

TOMI Environmental Solutions

Legal name

TOMI Environmental Solutions, Inc.

Website

https://tomiesinc.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Environmental disinfection and biosecurity equipment

NAICS

Chemical Manufacturing (325), Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413)

SIC

Specialty Cleaning, Polishing And Sanitation Preparations (2842), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB)

akta.pro secondary industries

Industrial & Institutional (I&I) Cleaning Chemicals (IMAEABAG), Waste & Hazardous Materials Management (incl. HazMat) (BPAHAJAK)

Keywords

• Environmental disinfection equipment
• Hydrogen peroxide decontamination
• Infection control technology
• Biosecurity decontamination systems
• Cleanroom sterilization solutions

Headquarters

HQ city

Frederick

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Equipment and Hardware Sales: Sale of SteraMist delivery systems including iHP decontamination units and Custom Engineered Systems. Strong equipment sales drove 5% year-over-year revenue increase in Q1 2026. Includes SteraMist Hybrid systems for laboratory and cleanroom installations.
2. BIT Solution Consumables (Razor-Blade Model): High-margin recurring consumable revenue from Binary Ionization Technology solution refills. BIT solution sales increased from $872,380 in 2024 to $1,065,172 in 2025. Q1 2026 BIT solution sales reached approximately $427,000 as installed base of delivery systems drives recurring revenue.
3. Decontamination Services: Service revenue including facility-wide disinfection services, training, and support. Mexican dairy contract valued at approximately $128,000 annually for SteraMist Environment System deployment and BIT Solution purchases.
4. Merged Entity with Carbonium Core: Pending merger with Carbonium Core, Inc. would diversify into nuclear-grade graphite production for advanced reactors and AI data center infrastructure, targeting multi-billion-dollar market driven by U.S. supply-chain reshoring. Transaction valued at $120 million.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels5 records

Core offering

TOMI Environmental Solutions designs, manufactures, and sells the SteraMist ionized Hydrogen Peroxide (iHP) decontamination platform based on its proprietary Binary Ionization Technology (BIT). The company offers equipment systems (SteraMist iHP units, Hybrid Systems, Environment Systems), recurring BIT Solution consumables, and Custom Engineered Systems (CES) for integration into pharmaceutical cleanrooms, research laboratories, food production facilities, and biosafety environments. Customers include hospitals, pharmaceutical manufacturers, food producers, defense agencies, research universities, and NASA.

Product overview

TOMI Environmental Solutions offers a unified product portfolio centered on its SteraMist® decontamination platform, which uses proprietary ionized Hydrogen Peroxide (iHP) technology based on Binary Ionization Technology (BIT). The core SteraMist platform provides hospital-grade environmental disinfection across healthcare, pharmaceutical, research, and industrial applications. The product ecosystem includes the SteraMist iHP equipment line, SteraMist Hybrid System for automated continuous decontamination, and the SteraMist Environment System for facility-wide deployment. BIT Solution serves as the recurring consumable revenue driver. Custom Engineered Systems enable bespoke integrations into customer infrastructure. Emerging autonomous capabilities extend the technology to drones, robotics, and AI-powered platforms for biosecurity applications. The company also holds a letter of intent to merge with Carbonium Core, Inc., which would diversify the portfolio into nuclear-grade graphite production.

Differentiator

Problem solved

Functional benefit

Brands

• SteraMist: ionized Hydrogen Peroxide (iHP) decontamination platform for disinfection and biosecurity applications across healthcare, pharmaceutical, food safety, and transportation sectors
• Binary Ionization Technology (BIT)

Products and services

• SteraMist iHP Decontamination System EPA-registered ionized Hydrogen Peroxide (iHP) decontamination equipment based on Binary Ionization Technology that produces a fine ionized H2O2 mist for hospital-grade environmental surface disinfection. Effective against Ebola, norovirus, hantavirus, measles, and other pathogens. Sold to healthcare facilities, hospitals, pharmaceutical cleanrooms, laboratories, transportation, and biosafety environments.
• SteraMist Hybrid System Automated decontamination solution integrating SteraMist iHP technology with modular platforms for continuous or scheduled high-level disinfection in laboratory settings, research facilities, pharmaceutical cleanrooms, and controlled environments. Deployed at East Coast research universities and UK pharmaceutical manufacturing facilities.
• SteraMist Environment System Facility-wide disinfection system delivering SteraMist iHP decontamination services for large-scale operations in food production, dairy, and industrial manufacturing environments to ensure continuous regulatory compliance and prevent production downtime.
• BIT Solution (Disinfectant Consumable) Proprietary disinfectant consumable used with SteraMist delivery systems, providing the ionized Hydrogen Peroxide formulation that enables high-level decontamination. BIT Solution sales represent the recurring high-margin revenue component driven by the installed base of SteraMist equipment.
• Custom Engineered Systems (CES) Bespoke integration solutions incorporating SteraMist iHP technology into customer-specific infrastructure, including modular cleanrooms, pharmaceutical manufacturing equipment, and proprietary medication systems. Includes long-term service contracts and custom engineering such as the iHP integration for a prominent American healthcare company's premixed ready-to-use medication system.

Quantifiable outcome

• 95% reduction in sanitation validation costs from $100,000 to $5,000 annually
• +5 more outcomes

Named customers11 records

Segments8 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered flagship, strategic and core.

• Carbonium Core, Inc.flagshipStrategic or Co-development Partner · 30 April 2026Non-binding letter of intent to merge with Carbonium Core, a U.S.-based producer of nuclear-grade graphite for advanced reactor technologies and AI data center infrastructure. Transaction valued at $120 million enterprise valuation with Carbonium Core becoming wholly owned subsidiary. Merger targets nuclear-grade graphite demand driven by U.S. supply-chain reshoring and next-generation reactor deployment. Definitive agreements expected by May 30, 2026.
• Oak Ridge National LaboratorystrategicTechnology or Integration · 30 April 2026Carbonium Core developed vertically integrated U.S. supply chain and exclusive purification technology in collaboration with Oak Ridge National Laboratory. Technology targets fourth-generation advanced reactor markets and AI data center infrastructure.
• DisinfectCarecoreChannel Partner/ Reseller/ Distributor · 24 March 2026Mexican service provider partnership enabling SteraMist iHP technology deployment in food production and dairy facilities. Supports facility-wide disinfection services with structured annual BIT Solution purchase agreements.
• Total Clean Air (TCA)coreChannel Partner/ Reseller/ Distributor · 3 March 2026TOMI appointed Total Clean Air as Preferred European Partner for SteraMist iHP decontamination technology covering sales, service, demonstration, and technical support across United Kingdom and European Union. TCA manages full customer lifecycle including maintenance, calibration, validation support with equipment hosted at Somerset showroom. Partnership targets life sciences and pharmaceutical sectors where UK infection control spending is projected to exceed $6 billion USD by 2031.

Scale indicators16 records

Recent moves7 records

Expansion highlights7 records

Emerging players

• Bio-Decon Solutions: Bio-Decon Solutions provides hydrogen peroxide and chlorine dioxide-based decontamination services for life sciences, pharmaceutical, and healthcare facilities as a focused service provider. As a smaller specialist, they compete with TOMI in pharma cleanroom and laboratory decontamination engagements with comparable service-led business models.

Broad incumbents

• Clorox: Clorox is a major manufacturer of cleaning, disinfecting, and sanitization products including bleach and hydrogen peroxide-based cleaners for consumer and institutional markets. Their professional products division competes with TOMI's BIT Solution consumable in commercial and institutional cleaning channels.
• STERIS: STERIS is a global leader in infection prevention and sterilization services, offering contract sterilization, disinfection, and contamination control across healthcare, pharmaceutical, and medical device end markets. TOMI's Custom Engineered Systems and decontamination services compete in adjacent pharmaceutical and healthcare sterilization segments.
• Ecolab: Ecolab is a global leader in water, hygiene, and infection prevention solutions, serving food safety, healthcare, hospitality, and industrial markets with cleaning chemicals, sanitizers, and decontamination services. Ecolab's Bioquell subsidiary overlaps directly with SteraMist while Ecolab's broader portfolio competes with TOMI's food safety and facility hygiene applications.
• Halma plc: Halma is a diversified group of safety, environmental, and medical technology companies including those in healthcare sterilization, infection control, and water quality monitoring. Several Halma subsidiaries (e.g., in healthcare disinfection and analytical instruments) overlap with TOMI's infection prevention and biosecurity offerings.
• Getinge: Getinge is a Swedish medical technology company providing infection control, surgical workflows, and ICU solutions including sterilization equipment and disinfection systems for hospitals and life sciences. Overlaps with TOMI in hospital and pharmaceutical sterilization/decontamination applications.
• Cantel Medical (now part of Stericycle): Cantel Medical (acquired by Stericycle) provides infection prevention products and services including endoscope reprocessing, water purification, and dental infection control. Their healthcare infection prevention portfolio competes with TOMI's hospital and healthcare decontamination offerings.

Direct peers

• Bioquell (Ecolab): Bioquell, now part of Ecolab, is the most direct competitor to TOMI's SteraMist platform, specializing in hydrogen peroxide vapor bio-decontamination for pharmaceutical, healthcare, and research environments. Both companies compete head-to-head in pharma cleanroom decontamination and life sciences sterile manufacturing applications.
• ClorPro Services: ClorPro Services provides bio-decontamination services and consulting using chlorine dioxide and hydrogen peroxide-based technologies for pharmaceutical, biotech, and research facilities. They directly compete with SteraMist in pharma cleanroom and laboratory decontamination engagements.

Regional players

• Stericycle: Stericycle is a leading provider of medical waste management, secure information destruction, and compliance services with significant North American and European presence. Their regulated waste services are adjacent to TOMI's hospital and pharmaceutical decontamination offerings though focused on waste rather than facility disinfection.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tomiesinc
• LinkedInlinkedin.com/company/2521796
• Facebookfacebook.com/tomiesinc

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TOMI Environmental Solutions